Br J Haematol. 2016 Nov 11. doi: 10.1111/bjh.14420. [Epub ahead of print]
Clinical utility of next-generation sequencing-based minimal residual disease in paediatric B-cell acute lymphoblastic leukaemia.
Sekiya Y1, Xu Y1, Muramatsu H1, Okuno Y1, Narita A1, Suzuki K1, Wang X1, Kawashima N1, Sakaguchi H2, Yoshida N2, Hama A1, Takahashi Y1, Kato K2, Kojima S1.
© 2016 John Wiley & Sons Ltd.
minimal residual disease; next-generation sequencing; paediatric acute lymphoblastic leukaemia; prognosis for relapse
- [PubMed - as supplied by publisher]